Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting

Introduction and Aims: To project the long-term cost-effectiveness of treating non-valvular atrial fibrillation (AF) patients for stroke prevention with rivaroxaban compared to warfarin in Portugal. Methods: A Markov model was used that included health and treatment states describing the management...

Full description

Bibliographic Details
Main Authors: João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Revista Portuguesa de Cardiologia
Online Access:http://www.sciencedirect.com/science/article/pii/S087025511400184X

Similar Items

Similar Items